The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer
Aim: We explore the biomarker potential of the TERT hypermethylated oncologic region (THOR) in pancreatic cancer. Materials & methods: We assessed the methylation status of THOR using the cancer genome atlas data on the cohort of pancreatic cancer (n = 193 patients). Results: THOR was significan...
Autor principal: | |
---|---|
Outros Autores: | , , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2019
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10400.1/12962 |
País: | Portugal |
Oai: | oai:sapientia.ualg.pt:10400.1/12962 |